By: Anonymous
Organisasi/ Individu: Individu
Kod Polisi: 3i Kesihatan
Isu dan Polisi Semasa:
Although my country’s T&CM industry’s legislation has been enforced in the second stage, the ambiguity and ambiguity of many policies have caused the industry to be very troubled and unable to follow suit. For example, whether the review of traditional medicines should be handled by a dedicated comittee instead of the existing NPRA department. Regarding the application of drugs in the Chinese medicine industry, refer to countries such as China, Taiwan, Hong Kong and Macau, and even the United States and Australia, whether they can hire third-party neutral persons to formulate more specific prescription and non-prescription guidelines.
Nilai-nilai & Kepercayaan
This will benefit Malaysia people to obtain safe and reliable services and medicines in traditional and auxiliary medical care.
Penyelesaian:
Appointments of members for the special and dedicated T&CM comittee should come from different party or association and not a stakeholder on industry business. Bahagian Perubatan Tradisional dan Komplementari(BPTK) should establish a drug review comittee on T&CM to discuss. Based on the fact that some drugs are also affected by different laws and regulations, the comittee established by BPTK should discuss how to use Pengamal Perubatan Tradisional dan Komplementari.
Sumber Rujukan: